Sur C, Farrar S J, Kerby J, Whiting P J, Atack J R, McKernan R M
Department of Biochemistry and Molecular Biology, Neuroscience Research Centre, Merck Research Laboratories, Harlow, Essex, United Kingdom.
Mol Pharmacol. 1999 Jul;56(1):110-5. doi: 10.1124/mol.56.1.110.
Pharmacological study of rat thalamic gamma-aminobutyric acidA (GABAA) receptors revealed the presence of two distinct populations, namely, diazepam-sensitive and diazepam-insensitive [3H]Ro15-4513 binding sites accounting for 94 +/- 2% (1339 +/- 253 fmol/mg protein) and 6 +/- 2% (90 +/- 44 fmol/mg protein) of total sites, respectively. Thalamic diazepam-insensitive sites exhibited a pharmacology that was distinct from diazepam-sensitive sites but comparable to that of the alpha4beta3gamma2 subtype of the GABAA receptor stably expressed in L(tk-) cells. Immunoprecipitation experiments with a specific anti-alpha4-antiserum immunoprecipitated 20 and 7% of total thalamic [3H]muscimol and [3H]Ro15-4513 sites, respectively. Combinatorial immunoprecipitation using antisera against the alpha4, gamma2, and delta subunit revealed that alpha4delta- and alpha4gamma2-containing receptors account for 13 +/- 2 and 8 +/- 3% of [3H]muscimol sites from thalamus, respectively. It also indicated that all delta subunits coexist with an alpha4 subunit in this brain region. In conclusion, our results show that in rat thalamus both alpha4betagamma2 and alpha4betadelta subtypes are expressed but alpha4betadelta is the major alpha4-containing GABAA receptor population.
对大鼠丘脑γ-氨基丁酸A(GABAA)受体的药理学研究表明,存在两种不同的类型,即地西泮敏感型和地西泮不敏感型[3H]Ro15-4513结合位点,分别占总位点的94±2%(1339±253 fmol/mg蛋白)和6±2%(90±44 fmol/mg蛋白)。丘脑地西泮不敏感型位点表现出与地西泮敏感型位点不同的药理学特性,但与在L(tk-)细胞中稳定表达的GABAA受体α4β3γ2亚型的药理学特性相当。用特异性抗α4抗血清进行的免疫沉淀实验分别沉淀了丘脑总[3H]蝇蕈醇和[3H]Ro15-4513位点的20%和7%。使用针对α4、γ2和δ亚基的抗血清进行的组合免疫沉淀表明,含α4δ和α4γ2的受体分别占丘脑[3H]蝇蕈醇位点的13±2%和8±3%。这也表明在该脑区所有δ亚基都与α4亚基共存。总之,我们的结果表明,在大鼠丘脑中,α4βγ2和α4βδ亚型均有表达,但α4βδ是含α4的主要GABAA受体类型。